Venipuncture: Clinical Trials

4 trials of Venipuncture, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed, 1 terminated, 1 withdrawn. 4 Phase 1, 2 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 14Completed 2, Terminated 1, Withdrawn 1
Phase 22Completed 2

Follow Venipuncture: new trials by email Literature Review of Venipuncture trials Research Report on Venipuncture

Trials (filtered) newest first · largest first

All 4 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
MicroRNA and MicroRNA Inhibitors Socket Study, Pilot Clinical Trial
tooth extraction, CBCT scan, Anesthesia - Tooth Extraction Status Nos
Phase 1WithdrawnGustavo Avila-Ortiz DDS, MS, PhD2025-12-312019-07-17
Treg Therapy in Subclinical Inflammation in Kidney Transplantation
Polyclonal Regulatory T Cells, Everolimus, Tacrolimus - Kidney Transplant, Adult Living Donor Kidney Transplant Recipients
Phase 1 / Phase 2CompletedNational Institute of Allergy and Infectious Diseases (NIAID)322016-09-202026-09-24
Donor-Alloantigen-Reactive Regulatory T Cell (darTregs) in Liver Transplantation
Anti-Thymocyte Globulin - Rabbit, darTreg Infusion, Everolimus - Liver Transplantation
Phase 1TerminatedNational Institute of Allergy and Infectious Diseases (NIAID)152014-12-172020-09-22
Phase I/II Thymus Transplantation With Immunosuppression #950
Cultured Thymus Tissue for Implantation (CTTI), Cultured Thymus Tissue Implantation and Parental Parathyroid Transplantation, Blood Draw - DiGeorge Anomaly, Complete DiGeorge Anomaly
Phase 1 / Phase 2CompletedSumitomo Pharma Switzerland GmbH142005-12-192022-03-25

Conditions studied

DiGeorge Syndrome (1)  ·  Hypocalcemia (1)  ·  Hypoparathyroidism (1)  ·  Immunologic Deficiency Syndromes (1)  ·  Thymic aplasia (1)

Sponsors

National Institute of Allergy and Infectious Diseases (NIAID) (2)  ·  Gustavo Avila-Ortiz DDS, MS, PhD (1)  ·  Sumitomo Pharma Switzerland GmbH (1)

Countries

United States (4)

Top investigators

Brad Amendt, MS (1)  ·  Flavio Vincenti, MD (1)  ·  Jeffrey Bluestone, PhD (1)  ·  M. Louise Markert, MD, PhD (1)  ·  Qizhi Tang, PhD (1)  ·  Sandy Feng, MD, PhD (1)  ·  Sang-Mo Kang, MD, FACS (1)  ·  Sindhu Chandran, MD (1)

Results publications

PMID 18035553, PMID 18424759, PMID 18557726, PMID 19066739, PMID 20236866, PMID 23607606

NIH funding

K12HD043494 (1), R01AI047040 (1), R01AI054843 (1), R34AI095135 (1), U01AI110658 (1)